Synopsis
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as vocal biomarker, by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
The global Vocal Biomarker market size is expected to reach US$ 3650.4 million by 2029, growing at a CAGR of 12.5% from 2023 to 2029. The market is mainly driven by the significant applications of Vocal Biomarker in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Vocal Biomarker market. Frequency, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Amplitude segment is estimated at % CAGR for the next seven-year period.
These vocal biomarkers are deemed to have immense potential in diagnosing disease based on vocal cues. As part of ongoing breakthroughs, a group of researchers from the New York University Langone Medical Center is developing a machine learning-based artificial intelligence (AI) system that would be capable of analyzing various voice characteristics that include rhythm, tone, and pitch from patients.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vocal Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vocal Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vocal Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vocal Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vocal Biomarker covered in this report include Beyond Verbal Communication, Sonde Health, IBM and Cogito, etc.
The global Vocal Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Beyond Verbal Communication
Sonde Health
IBM
Cogito
Global Vocal Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vocal Biomarker market, Segment by Type:
Frequency
Amplitude
Error Rate
Phonation Time
Pitch
Others
Global Vocal Biomarker market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vocal Biomarker companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Vocal Biomarker
1.1 Vocal Biomarker Market Overview
1.1.1 Vocal Biomarker Product Scope
1.1.2 Vocal Biomarker Market Status and Outlook
1.2 Global Vocal Biomarker Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Vocal Biomarker Market Size by Region (2018-2029)
1.4 Global Vocal Biomarker Historic Market Size by Region (2018-2023)
1.5 Global Vocal Biomarker Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Vocal Biomarker Market Size (2018-2029)
1.6.1 North America Vocal Biomarker Market Size (2018-2029)
1.6.2 Europe Vocal Biomarker Market Size (2018-2029)
1.6.3 Asia-Pacific Vocal Biomarker Market Size (2018-2029)
1.6.4 Latin America Vocal Biomarker Market Size (2018-2029)
1.6.5 Middle East & Africa Vocal Biomarker Market Size (2018-2029)
2 Vocal Biomarker Market by Type
2.1 Introduction
2.1.1 Frequency
2.1.2 Amplitude
2.1.3 Error Rate
2.1.4 Phonation Time
2.1.5 Pitch
2.1.6 Others
2.2 Global Vocal Biomarker Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Vocal Biomarker Historic Market Size by Type (2018-2023)
2.2.2 Global Vocal Biomarker Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Vocal Biomarker Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Vocal Biomarker Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Vocal Biomarker Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Vocal Biomarker Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Vocal Biomarker Revenue Breakdown by Type (2018-2029)
3 Vocal Biomarker Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Vocal Biomarker Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Vocal Biomarker Historic Market Size by Application (2018-2023)
3.2.2 Global Vocal Biomarker Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Vocal Biomarker Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Vocal Biomarker Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Vocal Biomarker Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Vocal Biomarker Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Vocal Biomarker Revenue Breakdown by Application (2018-2029)
4 Vocal Biomarker Competition Analysis by Players
4.1 Global Vocal Biomarker Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vocal Biomarker as of 2022)
4.3 Date of Key Players Enter into Vocal Biomarker Market
4.4 Global Top Players Vocal Biomarker Headquarters and Area Served
4.5 Key Players Vocal Biomarker Product Solution and Service
4.6 Competitive Status
4.6.1 Vocal Biomarker Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Beyond Verbal Communication
5.1.1 Beyond Verbal Communication Profile
5.1.2 Beyond Verbal Communication Main Business
5.1.3 Beyond Verbal Communication Vocal Biomarker Products, Services and Solutions
5.1.4 Beyond Verbal Communication Vocal Biomarker Revenue (US$ Million) & (2018-2023)
5.1.5 Beyond Verbal Communication Recent Developments
5.2 Sonde Health
5.2.1 Sonde Health Profile
5.2.2 Sonde Health Main Business
5.2.3 Sonde Health Vocal Biomarker Products, Services and Solutions
5.2.4 Sonde Health Vocal Biomarker Revenue (US$ Million) & (2018-2023)
5.2.5 Sonde Health Recent Developments
5.3 IBM
5.3.1 IBM Profile
5.3.2 IBM Main Business
5.3.3 IBM Vocal Biomarker Products, Services and Solutions
5.3.4 IBM Vocal Biomarker Revenue (US$ Million) & (2018-2023)
5.3.5 Cogito Recent Developments
5.4 Cogito
5.4.1 Cogito Profile
5.4.2 Cogito Main Business
5.4.3 Cogito Vocal Biomarker Products, Services and Solutions
5.4.4 Cogito Vocal Biomarker Revenue (US$ Million) & (2018-2023)
5.4.5 Cogito Recent Developments
6 North America
6.1 North America Vocal Biomarker Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Vocal Biomarker Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Vocal Biomarker Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Vocal Biomarker Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Vocal Biomarker Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Vocal Biomarker Market Dynamics
11.1 Vocal Biomarker Industry Trends
11.2 Vocal Biomarker Market Drivers
11.3 Vocal Biomarker Market Challenges
11.4 Vocal Biomarker Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List